SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma-Reference-Cited by-同舟云学术

SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma

Published:2020-03-16 Issue:5 Volume:44 Page:607-616
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Karanian Marie,Pissaloux Daniel,Gomez-Brouchet Anne,Chevenet Carole,Le Loarer François,Fernandez Carla,Minard Veronique,Corradini Nadege,Castex Marie-Pierre,Duc-Gallet Adeline,Blay Jean-Yves,Tirode Franck

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference35 articles.

1. Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma;Mosquera;Genes Chromosomes Cancer,2013

2. A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related fusions in infantile cases;Alaggio;Am J Surg Pathol,2016

3. Transcriptomic definition of molecular subgroups of small round cell sarcomas;Watson;J Pathol,2018

4. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis;Agaram;Genes Chromosomes Cancer,2014

5. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations;Kohsaka;Nat Genet,2014

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OGT::FOXO1-fused myoepithelioma-like hyalinising epithelioid tumour arising in non-acral skin;Pathology;2024-10

2. Cellular Cutaneous Epithelioid Hemangioma Harboring the Rare GATA6::FOXO1 Gene Fusion;The American Journal of Dermatopathology;2024-04

3. Functional Classification of Fusion Proteins in Sarcoma;Cancers;2024-03-29

4. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry;Human Pathology;2023-12

5. An SRF‐rearranged malignant cellular myoid neoplasm with a novel SRF–MKL2 fusion;Pediatric Blood & Cancer;2023-09-16